Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21511,777,1.07 [0.93-1.23],0.3649604343720625
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21510,125,1.42 [1.08-1.86],0.0123193637451027
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22857,127,0.97 [0.68-1.39],0.8739804749486335
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17047,431,1.33 [1.13-1.57],0.0006126614105753
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22806,76,0.95 [0.60-1.51],0.8340851365564018
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22193,70,1.34 [0.92-1.96],0.1274777783530512
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23672,75,0.97 [0.62-1.54],0.9118837720726498
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23691,49,0.85 [0.46-1.56],0.6019939508737142
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21715,40,1.81 [1.25-2.64],0.0019126645714279
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23250,95,1.38 [1.00-1.90],0.0478171851287451
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23216,61,1.33 [0.88-2.01],0.1688658998886061
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23734,58,0.71 [0.39-1.28],0.2484675270399371
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23694,92,1.03 [0.69-1.55],0.8823692557528748
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23686,84,1.13 [0.76-1.69],0.53804488628536
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,23532,44,0.82 [0.43-1.57],0.5469915091305706
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22978,333,1.17 [0.96-1.43],0.1171570001351384
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22766,121,1.29 [0.96-1.74],0.0925933095716421
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22861,216,1.11 [0.86-1.43],0.4266750561790184
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20584,25,2.02 [1.33-3.06],0.0009986882535151
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20603,44,1.39 [0.88-2.22],0.161399853846387
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20668,109,0.89 [0.59-1.32],0.5542794842277199
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20673,114,0.92 [0.63-1.36],0.6766919216881692
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11580,252,1.19 [0.95-1.49],0.1379271075483296
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9253,22,1.63 [0.88-3.02],0.1195022095290246
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20601,42,1.26 [0.74-2.14],0.4002026148904447
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21930,703,1.22 [1.06-1.40],0.0045020757130816
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22856,173,1.18 [0.90-1.54],0.2237880408943536
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23384,71,1.15 [0.76-1.76],0.5049732344244514
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23800,66,1.33 [0.90-1.95],0.1560142885631242
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,23601,39,1.40 [0.87-2.25],0.1598065487371655
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23798,34,0.71 [0.33-1.52],0.3771096592968189
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Stomach,23834,27,0.82 [0.36-1.86],0.6370661973642212
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,23571,253,1.05 [0.83-1.34],0.6676836409873166
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23776,105,0.76 [0.49-1.17],0.2137471278949924
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23781,77,1.54 [1.12-2.12],0.0077146401080374
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23752,42,1.61 [1.07-2.43],0.0237821655409489
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",23754,42,1.61 [1.07-2.43],0.0237876555300963
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,23654,208,0.95 [0.72-1.26],0.7454096130294909
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23801,92,0.93 [0.61-1.42],0.7347538419697757
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,23721,158,0.83 [0.59-1.17],0.28733573483807
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of breast,13153,81,1.12 [0.75-1.67],0.5702249513893867
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Leiomyoma of uterus,12864,592,1.00 [0.85-1.18],0.993583327096885
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22988,166,1.39 [1.09-1.79],0.0084673682375024
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22877,299,1.31 [1.08-1.59],0.0065688153145003
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22877,299,1.31 [1.08-1.59],0.0065688153145003
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21837,307,1.04 [0.83-1.30],0.7318735309407407
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23400,74,1.33 [0.91-1.94],0.1360989612481025
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23619,83,1.20 [0.83-1.75],0.3349444719195777
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20887,606,1.04 [0.89-1.22],0.608349143198129
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22750,367,1.00 [0.81-1.23],0.9927321860408548
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22265,87,0.77 [0.48-1.24],0.2890487240823075
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23169,52,0.86 [0.49-1.53],0.6143755862757377
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22254,76,0.91 [0.56-1.47],0.6964812426913622
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22459,281,0.90 [0.69-1.16],0.4068852771803724
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22452,274,0.89 [0.69-1.16],0.400755916940711
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22163,152,1.08 [0.77-1.53],0.6515862276922766
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22166,149,1.11 [0.78-1.57],0.5620730185996299
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20752,471,0.93 [0.77-1.12],0.4383205488159204
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20346,65,1.02 [0.65-1.63],0.9167957854448516
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,20715,434,0.91 [0.75-1.11],0.3747009415977419
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20321,40,1.99 [1.43-2.78],4.833995677651324e-05
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20341,60,1.56 [1.09-2.23],0.0144878048852856
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,20654,661,0.98 [0.83-1.15],0.7820359334916958
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20261,268,0.71 [0.53-0.94],0.0176252137350497
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23470,202,0.74 [0.54-1.02],0.065066280480345
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23521,147,0.72 [0.50-1.05],0.0866838275936383
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22119,71,0.74 [0.44-1.27],0.2758354192861281
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23741,71,0.75 [0.45-1.28],0.2942731282731811
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20064,71,0.75 [0.44-1.28],0.2951970619075673
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Alcohol dependence,22135,87,0.66 [0.40-1.09],0.1023912292726768
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,22089,64,0.77 [0.45-1.32],0.348379006573462
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20060,67,1.01 [0.62-1.64],0.9641487284079948
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20316,323,1.12 [0.91-1.38],0.2716966465017054
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression,22338,282,1.18 [0.95-1.46],0.1390973595700547
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression or dysthymia,20195,246,1.08 [0.85-1.38],0.532986474367336
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20119,126,1.08 [0.77-1.50],0.6686486649597569
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Other anxiety disorders,22553,57,0.77 [0.43-1.37],0.370044516674627
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,21222,1274,1.08 [0.96-1.20],0.1977993129611915
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19763,157,1.47 [1.16-1.84],0.0011463953310057
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23651,128,1.54 [1.21-1.96],0.0003952422116003
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22698,423,1.05 [0.86-1.27],0.6503153624695117
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,22420,145,1.17 [0.86-1.59],0.3128234713852146
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,22359,84,1.09 [0.73-1.65],0.6651667973524085
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23520,75,1.22 [0.82-1.83],0.3280855025701353
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23406,36,0.82 [0.40-1.67],0.5847230177300926
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,22424,149,0.86 [0.60-1.22],0.3961944110001645
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,23309,115,0.87 [0.59-1.28],0.4765240263943394
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22853,540,1.09 [0.93-1.28],0.2951738782465155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22434,121,1.30 [0.96-1.75],0.0922999188551558
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22604,291,1.04 [0.83-1.30],0.7266013909440483
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23649,75,0.61 [0.35-1.04],0.0716556245507174
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,23623,49,0.63 [0.32-1.22],0.1706965213728241
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,23460,106,0.74 [0.48-1.14],0.1754235220863534
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23430,266,0.70 [0.53-0.93],0.0134436278813067
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23305,141,0.57 [0.38-0.85],0.0054384523687559
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23241,77,0.84 [0.51-1.37],0.4792305272633017
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23247,83,0.69 [0.42-1.14],0.1501594961754234
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23204,40,0.62 [0.29-1.29],0.1974932942390123
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22350,51,1.11 [0.67-1.85],0.6837413861791106
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22453,154,1.08 [0.80-1.46],0.6004570593995011
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23305,108,0.80 [0.53-1.21],0.2920651517752948
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23617,18,0.90 [0.34-2.40],0.8295041992398124
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1505,18,0.94 [0.36-2.47],0.8997198209893662
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22130,18,0.89 [0.33-2.39],0.8123709182202448
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23507,43,0.81 [0.42-1.55],0.5181900032488413
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23487,23,0.57 [0.21-1.53],0.2677009972543414
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23425,81,0.96 [0.61-1.50],0.8533524142193879
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23475,89,0.79 [0.50-1.25],0.3150833692065052
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23718,107,0.91 [0.62-1.36],0.6569087736445445
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23385,87,0.90 [0.58-1.40],0.6529072695477818
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18600,1697,0.96 [0.87-1.07],0.5024411048612076
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23564,38,1.60 [1.03-2.48],0.0350486052005352
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19515,1136,0.95 [0.83-1.08],0.4128608421857005
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,19529,1150,0.94 [0.83-1.07],0.3497885894889523
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18409,30,1.49 [0.92-2.42],0.1089842740610804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22544,496,0.92 [0.77-1.11],0.3896819367007417
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,22352,304,0.92 [0.73-1.16],0.493196384640656
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23222,121,0.82 [0.56-1.21],0.3262420676087648
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23325,224,0.84 [0.64-1.12],0.2407242443206857
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23742,51,0.67 [0.36-1.25],0.2080580184719928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22185,137,0.95 [0.67-1.33],0.7450122119520427
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22410,372,0.92 [0.75-1.14],0.4380585677604354
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23395,75,1.31 [0.90-1.90],0.1651899090901653
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23394,155,1.11 [0.82-1.48],0.5037112173240856
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23378,58,1.02 [0.61-1.69],0.9474330919949142
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23378,58,1.02 [0.61-1.69],0.9474330919949142
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18435,56,0.99 [0.59-1.67],0.968675405047276
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21569,38,0.91 [0.48-1.74],0.7769651872382084
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,21596,65,1.23 [0.81-1.86],0.3385650818253899
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16214,83,1.00 [0.64-1.56],0.986992477606959
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16302,171,1.10 [0.82-1.48],0.5174040978073957
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,21566,35,1.18 [0.64-2.16],0.6020083263569187
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21582,51,0.76 [0.41-1.41],0.3853952576556264
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23400,109,1.11 [0.79-1.56],0.548936515668426
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23363,98,0.64 [0.40-1.02],0.0603955765511785
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23393,74,0.69 [0.41-1.17],0.1689621716789708
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23435,65,0.75 [0.43-1.30],0.3092596747577832
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23182,44,1.42 [0.91-2.23],0.125033371546055
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23214,76,1.15 [0.77-1.74],0.4900104970712207
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22789,100,1.13 [0.78-1.63],0.517974273587547
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22772,83,0.72 [0.44-1.18],0.1917484979481135
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23696,80,0.68 [0.41-1.12],0.1318273014753916
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,23067,378,1.28 [1.07-1.52],0.0058333967269551
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,23214,45,1.33 [0.82-2.16],0.2434305617514459
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20156,1686,1.08 [0.98-1.19],0.1025911554776665
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23636,115,1.04 [0.73-1.49],0.830893096657813
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22811,159,1.25 [0.95-1.64],0.1041668327741679
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22786,134,1.25 [0.93-1.68],0.1337674900837018
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23286,193,1.05 [0.79-1.38],0.7487743264013995
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23285,192,1.04 [0.79-1.38],0.761597328049225
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23061,570,0.92 [0.77-1.09],0.3200397705972126
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,22578,87,1.34 [0.96-1.89],0.0873729820345921
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,22587,96,1.31 [0.95-1.82],0.1003155997151817
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22853,362,0.81 [0.64-1.02],0.0701264553624878
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,22679,188,0.78 [0.56-1.07],0.1228839701192735
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13682,42,0.93 [0.50-1.75],0.8297079908573959
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21802,766,1.21 [1.07-1.38],0.0032488505420803
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,23217,85,1.23 [0.86-1.76],0.2548110334834633
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23217,85,1.23 [0.86-1.76],0.2548110334834633
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23217,85,1.23 [0.86-1.76],0.2548110334834633
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22314,694,1.22 [1.07-1.39],0.0039923005214713
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Asthma,18191,694,1.21 [1.05-1.38],0.007273934035121
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18063,694,1.20 [1.05-1.38],0.0077656364019642
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18176,679,1.22 [1.06-1.40],0.005446699743413
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23669,54,1.54 [1.05-2.26],0.026102425396288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,22659,41,1.32 [0.79-2.18],0.2896941002345177
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23725,41,1.31 [0.78-2.18],0.3057129947579809
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22654,36,1.42 [0.86-2.35],0.1750133856453153
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,22659,65,1.44 [1.00-2.08],0.0482476218397155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,22754,160,1.23 [0.94-1.62],0.1301827021022234
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23103,76,0.96 [0.61-1.52],0.861673159299024
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16929,4442,1.09 [1.01-1.16],0.0195385042092424
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23316,428,1.18 [1.00-1.41],0.0567504282675779
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23772,117,1.05 [0.74-1.49],0.7854874834719975
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,23777,108,1.08 [0.75-1.55],0.6668583067622348
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,22994,106,1.19 [0.84-1.68],0.3324806260809588
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22985,97,1.19 [0.83-1.70],0.3356238290404563
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23761,132,1.03 [0.74-1.44],0.8535292962117649
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22966,78,1.22 [0.83-1.80],0.3119246452163091
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22754,56,0.97 [0.57-1.65],0.9171779049306656
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23728,41,1.14 [0.64-2.02],0.6513590276899739
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19172,177,1.19 [0.92-1.54],0.1818291802796927
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20513,1518,1.01 [0.91-1.12],0.9066764529330846
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,19226,231,1.00 [0.77-1.29],0.9806949141553414
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19479,484,1.05 [0.88-1.25],0.5825674972162043
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19054,59,0.98 [0.59-1.63],0.9282380521016936
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19117,122,0.96 [0.67-1.37],0.8040588904601864
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19022,27,0.76 [0.33-1.76],0.521851775846709
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,19085,90,1.11 [0.76-1.62],0.5980220348755052
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,19084,89,1.39 [1.02-1.91],0.0382397625073187
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23743,63,1.48 [1.04-2.12],0.0311271894773139
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,19091,96,0.75 [0.48-1.18],0.2081406048989529
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19550,555,1.05 [0.89-1.24],0.5365391647532058
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,23677,138,1.00 [0.72-1.40],0.9793663940316416
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,19331,336,1.05 [0.85-1.30],0.6437395094532434
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19096,101,0.83 [0.54-1.26],0.3841779225640379
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23664,171,0.98 [0.73-1.34],0.9217112875557704
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,23647,108,0.96 [0.65-1.41],0.8311914569294746
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,21483,1010,1.08 [0.96-1.22],0.2120536774023188
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,20807,334,0.99 [0.80-1.23],0.9364907371842984
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,20572,99,1.06 [0.72-1.57],0.7649553674531371
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,20550,77,1.45 [1.03-2.04],0.0350811205191579
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20998,525,1.02 [0.86-1.22],0.786626445071896
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23078,648,1.05 [0.91-1.23],0.4924626494354864
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,19614,1438,1.07 [0.97-1.19],0.1767512008838725
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23545,64,1.05 [0.66-1.69],0.8311159274275992
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23763,91,1.03 [0.69-1.54],0.897218662266799
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,22521,91,1.03 [0.69-1.54],0.8873397630300772
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22501,71,1.19 [0.78-1.80],0.4130564215924425
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23711,113,1.00 [0.69-1.44],0.9806508163888265
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,22543,113,1.00 [0.69-1.45],0.9949614384695824
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22526,96,0.91 [0.60-1.39],0.6671739845677268
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22950,520,1.07 [0.91-1.27],0.3971046357451298
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22946,516,1.08 [0.91-1.27],0.3914055150425312
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18236,60,1.32 [0.88-1.97],0.1820881912470172
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal stricture,23538,60,1.32 [0.88-1.99],0.184610387727916
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18220,44,1.27 [0.77-2.07],0.3476065792990563
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18442,266,1.14 [0.91-1.42],0.2576776924688594
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18322,146,0.82 [0.58-1.18],0.28649644462185
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18388,212,1.18 [0.92-1.50],0.1864794366570624
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,22840,188,1.23 [0.95-1.58],0.1130410730071714
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23472,76,1.32 [0.91-1.91],0.1400296640281284
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18335,159,0.90 [0.65-1.25],0.5214177647378913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18259,83,1.31 [0.92-1.86],0.1394877717975641
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18857,681,1.01 [0.87-1.18],0.8678116712682722
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,18329,153,1.06 [0.78-1.45],0.700186130705708
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23462,66,1.11 [0.70-1.74],0.6579559064998621
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,23209,108,1.27 [0.92-1.75],0.1486043894160036
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,23163,62,1.29 [0.86-1.93],0.2185747622157428
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22748,449,1.00 [0.83-1.21],0.9894164363821636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,22656,357,1.07 [0.88-1.31],0.5016536366319494
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,22361,62,1.06 [0.66-1.70],0.8135353130810417
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22334,35,1.12 [0.60-2.09],0.7170479544357156
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,22349,50,0.90 [0.50-1.61],0.7225839686122437
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23677,50,0.90 [0.50-1.60],0.7096139974834765
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22753,253,1.20 [0.96-1.50],0.1008429468177867
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22562,62,1.24 [0.81-1.90],0.3302439800579954
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,22550,50,1.40 [0.91-2.13],0.1244337752186501
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22538,38,1.28 [0.75-2.19],0.3632763893043925
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22658,158,1.10 [0.81-1.48],0.535401622996867
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,22653,153,1.08 [0.79-1.46],0.6446552112001922
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21627,1290,1.13 [1.01-1.26],0.0259271922973992
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23502,88,0.94 [0.61-1.45],0.7907690070962308
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23472,409,0.99 [0.81-1.21],0.9143107665836409
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22890,448,1.14 [0.96-1.36],0.1449411188240882
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23154,359,1.34 [1.13-1.59],0.000958969879779
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22893,98,1.66 [1.27-2.18],0.0002071445446524
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22996,201,1.26 [1.00-1.60],0.0533150586140028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23613,75,1.08 [0.70-1.66],0.7285360018335635
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23600,62,1.01 [0.62-1.66],0.9552448077142064
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23583,45,1.10 [0.63-1.90],0.7375631265782522
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23697,28,0.79 [0.35-1.80],0.5814544515089022
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23694,25,0.84 [0.36-1.96],0.6844577329065391
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23122,59,0.68 [0.38-1.23],0.2036889396650743
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23373,310,1.02 [0.82-1.28],0.8529580756760439
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22496,54,0.82 [0.45-1.47],0.4976140655086125
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22528,86,1.53 [1.13-2.06],0.0054221069156783
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22515,73,1.36 [0.94-1.97],0.1026571131616203
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22619,177,1.02 [0.76-1.37],0.9138916244387446
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22597,155,1.02 [0.75-1.41],0.8788891193816302
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18441,3031,1.04 [0.97-1.13],0.2835696206959592
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19801,1622,1.08 [0.98-1.19],0.1429506757664441
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21722,943,0.94 [0.83-1.08],0.4105546969024177
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18288,109,1.61 [1.24-2.08],0.000307854744685
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18487,308,1.30 [1.07-1.58],0.0076585989598072
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23541,104,1.60 [1.23-2.07],0.0003986758659276
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23553,92,1.59 [1.20-2.10],0.0010591531202028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18760,581,1.10 [0.94-1.29],0.2344041075410233
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20967,581,1.10 [0.94-1.29],0.2436216139297872
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18220,41,1.48 [0.96-2.28],0.076394800331639
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23513,40,1.50 [0.98-2.30],0.062368850755016
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18312,133,1.15 [0.84-1.56],0.3853222883907818
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18202,23,0.71 [0.28-1.82],0.4730582415545636
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18290,111,1.15 [0.82-1.61],0.4291680147530373
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23729,57,1.13 [0.71-1.80],0.6199309533746125
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18466,287,1.00 [0.79-1.26],0.9902570765365312
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18376,197,1.26 [0.99-1.60],0.0594309109693777
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19243,1064,0.98 [0.86-1.11],0.6985429643367242
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18213,34,1.32 [0.76-2.30],0.3269181321053874
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18327,148,0.98 [0.70-1.37],0.9095392961850952
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18202,23,0.86 [0.36-2.08],0.7440870580404736
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18202,23,1.05 [0.48-2.32],0.9008073739091588
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18620,441,0.96 [0.79-1.16],0.6573449106434415
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18546,367,0.94 [0.76-1.16],0.5558561295782952
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18805,245,1.06 [0.83-1.36],0.6343233019429193
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23482,143,1.17 [0.86-1.59],0.3063323049428806
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23376,37,1.24 [0.70-2.18],0.4555746872696914
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21279,42,0.89 [0.47-1.69],0.7244396815103523
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21434,197,1.07 [0.82-1.40],0.5961783561855409
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22022,785,1.02 [0.89-1.18],0.764667105460038
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21358,121,1.16 [0.84-1.59],0.3623906269539438
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21286,49,1.08 [0.63-1.83],0.7879507728329254
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21896,659,1.03 [0.89-1.20],0.6938638415114726
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21288,51,1.01 [0.60-1.72],0.965738066971342
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21457,220,1.10 [0.85-1.42],0.4596874966463433
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21335,98,1.23 [0.86-1.74],0.2532225369689006
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21297,60,1.01 [0.61-1.67],0.9700307284584504
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21357,120,1.05 [0.74-1.49],0.7831881852692792
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21295,58,1.02 [0.61-1.70],0.9473242917058864
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21521,284,1.11 [0.89-1.38],0.335900704326773
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21018,239,0.96 [0.73-1.24],0.7349963102819945
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20823,44,0.66 [0.33-1.31],0.2300218059843946
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20821,42,0.92 [0.49-1.74],0.7955282662455487
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20880,101,1.31 [0.94-1.82],0.1075423681893215
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20830,51,1.03 [0.59-1.78],0.9197960819627108
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20833,54,0.82 [0.46-1.47],0.5083909537709066
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20820,41,1.00 [0.55-1.84],0.9966495476715443
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20963,184,1.02 [0.76-1.36],0.8942111019267144
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20824,45,1.05 [0.58-1.87],0.8792193548413455
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20822,43,0.92 [0.50-1.71],0.8029446202332717
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20872,93,0.92 [0.60-1.42],0.7160271965688565
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20845,66,0.99 [0.61-1.62],0.9835585642497006
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21157,378,0.93 [0.75-1.15],0.5137773571920872
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20910,131,1.02 [0.72-1.43],0.9298126243549926
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20979,200,0.98 [0.74-1.31],0.915281052030104
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22622,89,1.31 [0.92-1.87],0.1294556970717011
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22825,292,1.23 [1.00-1.50],0.0513437015583574
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22580,47,0.76 [0.40-1.45],0.4069746769523137
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22590,57,1.48 [1.02-2.14],0.0378129005930863
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22634,101,1.41 [1.05-1.91],0.0233365067660344
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20192,3735,1.17 [1.09-1.25],7.078798335378928e-06
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9660,342,1.17 [0.95-1.44],0.1359806784323375
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22557,157,1.43 [1.12-1.83],0.0044881977292618
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22443,43,1.24 [0.75-2.05],0.3929081131690006
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22703,33,1.25 [0.69-2.28],0.4652166394926208
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22699,29,2.42 [1.76-3.31],4.423520988016592e-08
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22707,37,1.93 [1.34-2.76],0.0003709389717753
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23514,197,0.93 [0.69-1.24],0.6235533674064653
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23587,47,1.18 [0.71-1.96],0.5315619798060683
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23453,136,0.74 [0.50-1.08],0.1148515945144115
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23400,83,1.20 [0.82-1.77],0.3467714179873962
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22527,754,1.14 [1.00-1.31],0.0486653037322299
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,21841,68,1.13 [0.72-1.76],0.6013361124810488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21829,56,1.15 [0.72-1.84],0.5616307975432249
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21927,154,0.99 [0.72-1.36],0.9434118208471014
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21854,81,1.20 [0.82-1.75],0.3591740296302447
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22304,531,1.21 [1.04-1.41],0.0147967439378929
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9379,61,1.13 [0.68-1.86],0.6387720908772876
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9349,31,1.76 [1.12-2.77],0.0142048638503848
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,9351,33,1.30 [0.71-2.38],0.4030801755417124
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9390,72,1.00 [0.62-1.61],0.9910863867536488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9375,57,0.88 [0.50-1.55],0.6567364175774222
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9398,80,1.21 [0.81-1.81],0.3610711009349771
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13035,218,1.28 [1.02-1.60],0.0354154060026178
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12883,66,1.35 [0.91-1.99],0.1364692968223397
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,12889,72,1.00 [0.63-1.58],0.9963339346161132
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12865,48,0.94 [0.52-1.69],0.8306115845594509
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12997,332,1.19 [0.98-1.44],0.0800788168580962
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12736,71,1.07 [0.69-1.67],0.7652196098624043
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12830,165,1.25 [0.96-1.62],0.093178893879585
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11994,2346,1.02 [0.93-1.11],0.6649690355396959
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,9897,249,0.92 [0.71-1.20],0.5541383243293053
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9728,80,0.96 [0.61-1.49],0.8439355235213635
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9744,96,0.86 [0.56-1.32],0.5002569431458987
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9913,265,0.89 [0.69-1.15],0.3888066062447523
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9907,259,1.03 [0.81-1.31],0.7896995559991142
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10050,402,1.01 [0.83-1.22],0.948983986999999
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9790,142,1.02 [0.74-1.40],0.8946005113864496
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9832,184,0.86 [0.63-1.18],0.3536179724648904
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9715,67,1.27 [0.87-1.85],0.2226618965567757
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9774,126,1.17 [0.85-1.61],0.3335460666220466
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13161,176,1.13 [0.86-1.49],0.3849018944214774
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13168,169,1.09 [0.82-1.46],0.5495921419334775
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13184,95,0.98 [0.65-1.48],0.9260432225152222
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13178,103,1.10 [0.76-1.59],0.6045883320198213
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9706,58,0.92 [0.54-1.57],0.7592013104400694
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9700,52,0.97 [0.56-1.69],0.9278578357992308
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9708,60,1.01 [0.61-1.66],0.9787993071154244
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,13097,315,0.94 [0.75-1.18],0.5846484750077323
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10613,965,0.98 [0.86-1.12],0.7994454021465967
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10309,661,1.00 [0.85-1.17],0.9928768329263148
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13169,137,0.88 [0.62-1.25],0.4859372973923305
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9945,297,0.95 [0.75-1.20],0.679800531036772
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9868,220,0.77 [0.57-1.04],0.0915205723350106
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9871,223,1.17 [0.92-1.48],0.1931792873355724
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female infertility,9732,84,1.01 [0.66-1.55],0.9549656051568244
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9725,77,0.99 [0.63-1.56],0.9753331160126494
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13178,719,0.99 [0.84-1.17],0.9315276658218414
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13186,990,1.02 [0.88-1.18],0.8050114533096486
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13179,374,1.12 [0.91-1.37],0.2852695774940899
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,12910,105,0.72 [0.45-1.13],0.1485055492652319
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,12956,151,1.36 [1.04-1.77],0.02466279776705
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,12938,133,1.14 [0.82-1.59],0.4198114340018009
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13194,138,0.78 [0.54-1.14],0.2027562968994175
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13196,136,0.76 [0.52-1.12],0.1680829797103692
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13192,351,0.89 [0.71-1.13],0.3341586197509186
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,12942,101,1.23 [0.88-1.71],0.232464668646998
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13040,199,0.95 [0.71-1.28],0.7428675761146026
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12583,124,1.03 [0.71-1.48],0.8831418906844976
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12622,163,0.88 [0.63-1.24],0.4652141004144086
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12659,200,1.14 [0.87-1.48],0.3414204913857602
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12580,121,0.98 [0.67-1.43],0.8990963965519955
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12572,113,1.22 [0.87-1.70],0.2440702441452232
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12582,123,0.88 [0.60-1.30],0.5137284773615798
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12387,191,1.05 [0.80-1.39],0.7217128151075618
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12564,368,1.12 [0.92-1.38],0.262631445512386
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12747,551,1.10 [0.92-1.32],0.2829581290962576
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13199,145,1.01 [0.72-1.41],0.9697516382791024
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,11999,110,0.88 [0.58-1.34],0.5545052880344084
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12281,85,1.04 [0.67-1.60],0.8723959887111699
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13203,280,1.07 [0.84-1.36],0.5881361162710563
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13142,219,1.01 [0.76-1.33],0.9534136590576616
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13192,203,1.12 [0.86-1.46],0.3993949164498429
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13183,194,1.13 [0.86-1.49],0.3653727501164914
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23620,32,0.55 [0.24-1.28],0.1683047548703193
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22420,442,0.98 [0.81-1.19],0.8592429807225894
